Fake news is emerging as a scourge; influencing amongst others, presidential elections and share prices.Read article
Three CAPRISA studies provide new information on high rates of HIV infection in young women in South Africa resulting from the “cycle of HIV transmission” involving age-disparate sex and on two vaginal bacteria - one increasing HIV vulnerability and another undermining the efficacy of tenofovir-based topical pre-exposure prophylaxis.Read article
JOHANNESBURG - Former President Thabo Mbeki has defended his controversial stance on HIV/Aids.Read article
"Congratulations to the ASPIRE and the Ring study teams for two well conducted studies. Both these studies have generated valuable new findings and insights," said Professor Salim S. Abdool Karim, Director of CAPRISA in response to the trial results (released at CROI today),Read article
The article “What’s all the noise about? ‘Dr Death’ says what he did for the apartheid state was ‘same as developing new Aids drug’” (17 January 2016) refers. Dr Wouter Basson’s arguments in justifying his apartheid-inspired research by describing it as analogous to AIDS drug development is outrageous in several respects:Read article
CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.